Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial

Overview of attention for article published in Nature Medicine, June 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 101 news outlets
blogs: 10 blogs
twitter: 55 X users
facebook: 2 Facebook pages

reddit: 4 Redditors
guideline: 1 clinical guideline source
bluesky: 1 Bluesky user

Readers on

mendeley: 117 Mendeley

So far, Altmetric has seen 61 X posts from 55 X users, with an upper bound of 2,818,507 followers.

RT @nirmalregency: Never knew Ketamine had tablet formulations too. It is never too late to learn. https://t.co/Y3UT1oKHvU

Never knew Ketamine had tablet formulations too. It is never too late to learn. https://t.co/Y3UT1oKHvU https://t.co/swAkTgM53u

RT @NatureMedicine: A Phase 2 dosing-finding study of an extended-release tablet formulation of #ketamine in patients with treatment-resist…

Another Prof Young study in Nature Medicine reported that extended-release ketamine tablets are effective, safe, and well-tolerated for treatment-resistant depression, offering a promising new oral treatment option. https://t.co/IQMNiE6JYE

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 57 additional X posts.